Another study showed that in breast cancer, the downregulation of Anp32e inhibits the proliferation, migration, and invasion of tumor cells by blocking EMT 15, indicating that Anp32e promotes the occurrence of EMT, which is an important mechanism underlying RIF 29, 30. Here, ANP32E is linked to breast cancer.